Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

BACKGROUND & AIMS: Treatment with non-selective beta-blockers (NSBBs) reduces the risk of ascites, which is the most common decompensating event in cirrhosis. This study aimed to assess the ability of a serum microRNA (miRNA) signature to predict ascites formation and the hemodynamic response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia Garcia de Paredes, Ana, Villanueva, Càndid, Blanco, Carolina, Genescà, Joan, Manicardi, Nicolo, Garcia-Pagan, Juan Carlos, Calleja, Jose Luis, Aracil, Carlos, Morillas, Rosa M., Poca, Maria, Peñas, Beatriz, Augustin, Salvador, Abraldes, Juan G., Alvarado, Eldimar, Royo, Félix, Garcia-Bermejo, Maria Laura, Falcon-Perez, Juan Manuel, Bañares, Rafael, Bosch, Jaime, Gracia-Sancho, Jordi, Albillos, Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531668/
https://www.ncbi.nlm.nih.gov/pubmed/34712934
http://dx.doi.org/10.1016/j.jhepr.2021.100368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531668/
https://www.ncbi.nlm.nih.gov/pubmed/34712934
http://dx.doi.org/10.1016/j.jhepr.2021.100368

Ejemplares similares